A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls.

Ronaldson KJ, Fitzgerald PB, Taylor AJ, Topliss DJ, McNeil JJ. A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls. Aust N Z J Psychiatry. 2011;45(6):458-65. DOI: 10.3109/00048674.2011.572852. PubMed PMID: 21524186.

Clozapine-induced myocarditis after long-term treatment: case presentation and clinical perspectives.

Lang UE, Willbring M, von Golitschek R, Schmeisser A, Matschke K, Malte Tugtekin S. Clozapine-induced myocarditis after long-term treatment: case presentation and clinical perspectives. J Psychopharmacol. 2008;22(5):576-80. DOI: 10.1177/0269881107082136. PubMed PMID: 18308817.

Rapid Rechallenge with Clozapine Following Pronounced Myocarditis in a Treatment-Resistant Schizophrenia Patient.

Ittasakul P, Archer A, Kezman J, Atsariyasing W, Goldman MB. Rapid Rechallenge with Clozapine Following Pronounced Myocarditis in a Treatment-Resistant Schizophrenia Patient. Clin Schizophrenia Relat Psychoses. 2016;10(2):120-2. DOI: 10.3371/1935-1232-10.2.120. PubMed PMID: 27440213.

Successful clozapine retrial after suspected myocarditis.

Rosenfeld AJ, Gibbs T, Ivie R, Clarke L, Merrill DB. Successful clozapine retrial after suspected myocarditis. AJP. 2010;167(3):350-1. DOI: 10.1176/appi.ajp.2009.09081118. PubMed PMID: 20194490.

An update expert opinion on management and research strategies in Parkinson's disease psychosis.

Goldman JG, Vaughan CL, Goetz CG. An update expert opinion on management and research strategies in Parkinson's disease psychosis. Expert Opin Pharmacother. 2011;12(13):2009-24. DOI: 10.1517/14656566.2011.587122. PubMed PMID: 21635198; PubMed Central PMCID: PMC3152685.

Clozapine in drug-induced psychosis in Parkinson's disease. The French Clozapine Parkinson Study Group.

Clozapine in drug-induced psychosis in Parkinson's disease. The French Clozapine Parkinson Study Group. Lancet. 1999;353(9169):2041-2. PubMed PMID: 10376627.

Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease.

Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. N Engl J Med. 1999;340(10):757-63. DOI: 10.1056/NEJM199903113401003. PubMed PMID: 10072410.

An eight-year clinic experience with clozapine use in a Parkinson's disease clinic setting.

Hack N, Fayad SM, Monari EH, Akbar U, Hardwick A, Rodriguez RL, et al. An eight-year clinic experience with clozapine use in a Parkinson's disease clinic setting. Plos One. 2014;9(3):e91545. DOI: 10.1371/journal.pone.0091545. PubMed PMID: 24646688; PubMed Central PMCID: PMC3960134.

Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial.

Larsen JR, Vedtofte L, Jakobsen MSL, Jespersen HR, Jakobsen MI, Svensson CK, et al. Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial. Jama Psychiatry. 2017;74(7):719-728. DOI: 10.1001/jamapsychiatry.2017.1220. PubMed PMID: 28601891.

A review of the effects of nicotine on schizophrenia and antipsychotic medications.

Lyon ER. A review of the effects of nicotine on schizophrenia and antipsychotic medications. PS. 1999;50(10):1346-50. DOI: 10.1176/ps.50.10.1346. PubMed PMID: 10506305.